Search Results - Chaoneng He

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer by Haiying Ding, Luo Fang, Wenxiu Xin, Xinglu Xu, Shujing Li, Weiben Xu, Chaoneng He, ZhaJun Zhan

    Published in BMJ Open (2024-07-01)
    Get full text
    Article


  2. 2

    Reply to “A better interpretation of data regarding the opioid switching to methadone” by Haiying Ding, Yu Song, Wenxiu Xin, Jiao Sun, Like Zhong, Qinfei Zhou, Chaoneng He, Liyan Gong, Luo Fang

    Published in BMC Palliative Care (2023-06-01)
    Get full text
    Article


  3. 3

    Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China. by Chaoneng He, Xiufang Mi, Gaoqi Xu, Xinglu Xu, Wenxiu Xin, Like Zhong, Junfeng Zhu, Qi Shu, Luo Fang, Haiying Ding

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  4. 4

    Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China by Chaoneng He, Xiufang Mi, Gaoqi Xu, Xinglu Xu, Wenxiu Xin, Like Zhong, Junfeng Zhu, Qi Shu, Luo Fang, Haiying Ding

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


Search Tools: